NVAX short interest
Novavax Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 46,046,946 |
|---|---|
| Change vs prior report | -3,828,264 (-7.7%) |
| Change over six months | +2.3% |
| Days to cover | 8.06 (sector: 3.78) |
| Average daily volume | 5,714,870 |
| Rank in Healthcare | #195 of 922 by days to cover |
NVAX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 46,046,946 | -7.7% | 8.06 | 5,714,870 |
| 2026-09-15 | 49,875,210 | +2.2% | 9.28 | 5,372,798 |
| 2026-08-31 | 48,784,134 | +2.7% | 8.61 | 5,663,047 |
| 2026-08-14 | 47,494,355 | +4.0% | 14.03 | 3,384,229 |
| 2026-07-31 | 45,659,491 | +4.2% | 16.63 | 2,746,393 |
| 2026-07-15 | 43,821,227 | -4.3% | 11.43 | 3,835,115 |
| 2026-06-30 | 45,809,886 | +1.5% | 9.28 | 4,935,619 |
| 2026-06-15 | 45,113,281 | -1.9% | 10.79 | 4,181,161 |
| 2026-05-29 | 45,965,363 | +1.5% | 7.84 | 5,866,242 |
| 2026-05-15 | 45,278,456 | -8.5% | 6.35 | 7,134,181 |
| 2026-04-30 | 49,475,862 | +6.8% | 17.25 | 2,868,230 |
| 2026-04-15 | 46,337,264 | +3.0% | 15.00 | 3,089,875 |
| 2026-03-31 | 44,990,492 | -7.5% | 10.62 | 4,235,772 |
| 2026-03-13 | 48,625,229 | -4.5% | 11.29 | 4,305,113 |
| 2026-02-27 | 50,923,803 | +0.1% | 8.75 | 5,819,093 |
| 2026-02-13 | 50,853,112 | -0.6% | 13.51 | 3,764,371 |
| 2026-01-30 | 51,181,637 | -3.9% | 6.55 | 7,816,056 |
| 2026-01-15 | 53,277,184 | -2.6% | 10.84 | 4,915,648 |
| 2025-12-31 | 54,721,714 | +4.0% | 17.00 | 3,219,864 |
| 2025-12-15 | 52,590,573 | +1.4% | 17.09 | 3,076,395 |
| 2025-11-28 | 51,861,435 | +2.3% | 13.39 | 3,874,547 |
| 2025-11-14 | 50,682,588 | +4.9% | 10.47 | 4,838,850 |
| 2025-10-31 | 48,322,992 | +5.4% | 12.92 | 3,740,286 |
| 2025-10-15 | 45,828,036 | +5.5% | 9.01 | 5,084,620 |
| 2025-09-30 | 43,445,298 | -2.9% | 10.93 | 3,973,449 |
import finzdata as yf
yf.Ticker("NVAX").short_interest # every report since 2017
yf.Client().short_interest(["NVAX"], start="2018-01-01")Healthcare short interest · NVAX price history · Who owns NVAX · All short interest